Re-activated t-cells for adoptive immunotherapy
作者： Micheal L. Gruenberg
DOI:
关键词:
摘要: A method for increasing the cytokine production of T-cells intended use in adoptive immunotherapy is provided. The improves methods where efficacy treatment dependent, at least part, on amount from cells. In practicing method, ex-vivo produced protocols are allowed to rest after harvest and then re-activated just prior infusion.
glgoo.top参考文章(84)
Allen S. Reichler, Scott T. Waniger, Bruce P. Amiot, Martin H. Banas, Process for improving mass transfer in a membrane bioreactor and providing a more homogeneous culture environment ,(1990)
Bernard Besnainon, Alain Philippe, Pierre Lessart, Marie-Paule Elluard, Mineral hollow fiber bioreactor for the cultivation of animal cells ,(1989)
Terry L. Bowlin, Sai P. Sunkara, Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor ,(1989)
David N. Bell, Truman Wong, Methods for the selective expansion of lymphocytes by in vitro cultivation ,(1998)
Micheal L. Gruenberg, Cell therapy system ,(2002)
Carina Henningsson, B. Michael Longenecker, Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype ,(1988)
James R. Robinson, Method and apparatus for culturing and diffusively oxygenating cells on isotropic membranes ,(1988)
Francis Brasseur, Thierry Boon-Falleur, Jean-Jacques Patard, Method for determining bladder tumors by assaying for MAGE-1,2,3 or 4 ,(1994)